Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Marasini

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Clinical Rheumatology|January 5, 2002
Iontophoretic evaluation of vascular reactivity to acetylcholine in patients with primary Raynaud's phenomenon and systemic sclerosisB Marasini, L Conciato
British Journal of Clinical Pharmacology|December 1, 1990
Digital blood flow and 5-hydroxytryptamine receptor blockade after ketanserin in patients with Raynaud's phenomenonB Marasini, C Bassani
American Journal of Clinical Pathology|February 1, 1977
Orosomucoid contents of pleural and peritoneal effusion of various etiologiesA Agostoni, B Marasini
International Journal of Immunopathology and Pharmacology|April 18, 2012
Statins and cardiovascular risk in rheumatic diseasesB Marasini, M Massarotti
Clinical and Experimental Rheumatology|April 16, 2004
Rheumatoid arthritis and thyroid diseaseB Marasini, M Massarotti
International Journal of Immunopathology and Pharmacology|June 10, 2009
Successful treatment with etanercept of a patient with psoriatic arthritis after adalimumab-related hepatotoxicityM Massarotti, B Marasini
Journal of Clinical Pathology|July 1, 1989
Abnormal platelet aggregation in patients with Raynaud's phenomenonM L Biondi, B Marasini
International Journal of Immunopathology and Pharmacology|January 4, 2006
Scleroderma heart diseaseB Marasini, M Massarotti, R Cossutta
Bollettino Della Societa Italiana Di Cardiologia|January 1, 1976
[Treatment of hereditary angioedema with a plasmatic concentrate of CU esterase inhibitor]B Marasini, M Cicardi, A Agostoni
Arthritis and Rheumatism|February 1, 1991
Plasma levels of tissue-type plasminogen activator and von Willebrand factor in patients with Raynaud's phenomenonB Marasini, M Cugno, A Agostoni
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Clinical Rheumatology|January 5, 2002
Iontophoretic evaluation of vascular reactivity to acetylcholine in patients with primary Raynaud's phenomenon and systemic sclerosisB Marasini, L Conciato
British Journal of Clinical Pharmacology|December 1, 1990
Digital blood flow and 5-hydroxytryptamine receptor blockade after ketanserin in patients with Raynaud's phenomenonB Marasini, C Bassani
American Journal of Clinical Pathology|February 1, 1977
Orosomucoid contents of pleural and peritoneal effusion of various etiologiesA Agostoni, B Marasini
International Journal of Immunopathology and Pharmacology|April 18, 2012
Statins and cardiovascular risk in rheumatic diseasesB Marasini, M Massarotti
Clinical and Experimental Rheumatology|April 16, 2004
Rheumatoid arthritis and thyroid diseaseB Marasini, M Massarotti
International Journal of Immunopathology and Pharmacology|June 10, 2009
Successful treatment with etanercept of a patient with psoriatic arthritis after adalimumab-related hepatotoxicityM Massarotti, B Marasini
Journal of Clinical Pathology|July 1, 1989
Abnormal platelet aggregation in patients with Raynaud's phenomenonM L Biondi, B Marasini
International Journal of Immunopathology and Pharmacology|January 4, 2006
Scleroderma heart diseaseB Marasini, M Massarotti, R Cossutta
Bollettino Della Societa Italiana Di Cardiologia|January 1, 1976
[Treatment of hereditary angioedema with a plasmatic concentrate of CU esterase inhibitor]B Marasini, M Cicardi, A Agostoni
Arthritis and Rheumatism|February 1, 1991
Plasma levels of tissue-type plasminogen activator and von Willebrand factor in patients with Raynaud's phenomenonB Marasini, M Cugno, A Agostoni
Pageof 6